News

MRI was highly accurate in identifying cancers that qualified for active surveillance, correctly predicting stable tumors in ...
The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
(Reuters) -The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to ...
Johnny Jackson, after playing his senior season while going through chemotherapy, received a surprise invitation to Madison ...
City of Hope unveils its largest outpatient cancer center, Hope Plaza, in Duarte. This state-of-the-art facility centralizes ...
The longtime ESPN broadcaster was first diagnosed with melanoma in 2021. He was also diagnosed with lymphoma, which he also ...
AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...
In Wednesday’s episode of their podcast, the “RHOBH” alum called in from a doctor’s appointment, where she was receiving immunotherapy treatment.
Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...
Researchers projected CT use in 2023 would lead to more than 100,000 future cancer diagnoses, and if trends continued, may ...
A new study reveals the shocking relationship between early-onset colorectal cancer and a super common disease that impacts ...